Odence-Ford Marion (CIK 0001845002)

Latest company ownership

OPRX - OptimizeRx Corp
Role: Chief Legal & Admin Officer
Shares held
6,649
Last filed at
Oct 7, 2025
Confidence Score
38.7
2025Q4
Confidence Score History
2022Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 23, 2025 Dec 23, 2025 OptimizeRx Corp Chief Legal & Admin Officer Sell 42.5 -4,051 -4.34% ✗ $51.6K
Dec 19, 2025 Dec 22, 2025 OptimizeRx Corp Chief Legal & Admin Officer Sell 46.3 -1,153 -1.22% ✗ $15.6K
Oct 3, 2025 Oct 7, 2025 OptimizeRx Corp Chief Legal & Admin Officer Sell 46.3 -1,952 -2.11% ✗ $36.6K
Mar 1, 2025 Mar 4, 2025 OptimizeRx Corp Chief Legal Officer & CHRO Sell 52.5 -268 -0.38% ✗ $1.4K
Feb 15, 2025 Feb 20, 2025 OptimizeRx Corp Chief Legal Officer & CHRO Sell 47.5 -1,479 -2.08% ✗ $9.8K
Feb 11, 2025 Feb 13, 2025 OptimizeRx Corp General Counsel and CCO Sell 47.5 -1,386 -1.91% ✗ $7.8K
Dec 19, 2024 Dec 20, 2024 OptimizeRx Corp General Counsel and CCO Sell 47.5 -1,153 -4.06% ✗ $5.5K
Nov 8, 2024 Nov 12, 2024 OptimizeRx Corp General Counsel and CCO Sell 47.5 -524 -2.10% ✗ $3.3K
Oct 3, 2024 Oct 7, 2024 OptimizeRx Corp General Counsel and CCO Sell 46.3 -1,952 -7.76% ✗ $15.3K
Mar 1, 2024 Mar 6, 2024 OptimizeRx Corp General Counsel and CCO Sell 47.5 -268 -1.85% ✗ $4.3K
Feb 11, 2024 Feb 13, 2024 OptimizeRx Corp General Counsel and CCO Sell 46.3 -1,386 -9.17% ✗ $21.3K
Jan 9, 2024 Jan 11, 2024 OptimizeRx Corp General Counsel and CCO Sell 22.5 -4,000 -26.47% ✗ $60.8K
Nov 8, 2023 Nov 13, 2023 OptimizeRx Corp General Counsel and CCO Sell 47.5 -524 -3.35% ✗ $4.8K
Oct 3, 2023 Oct 6, 2023 OptimizeRx Corp General Counsel and CCO Sell 46.3 -1,952 -12.35% ✗ $13.8K
Mar 1, 2023 Mar 3, 2023 OptimizeRx Corp General Counsel and CCO Sell 47.5 -268 -2.84% ✗ $4.9K
Feb 11, 2023 Feb 14, 2023 OptimizeRx Corp General Counsel and CCO Sell 46.3 -1,422 -14.11% ✗ $24.7K
Nov 8, 2022 Nov 10, 2022 OptimizeRx Corp General Counsel and CCO Sell 46.3 -710 -10.46% ✗ $10.3K
Aug 26, 2022 Aug 30, 2022 OptimizeRx Corp General Counsel and CCO Buy 91.3 +1,000 25.00% ✗ $15.8K